Skip to main content

Advertisement

SpringerLink
Log in

Clinicopathologic differences of mesenchymal submucosal tumors between the esophagogastric junction and the upper stomach

  • Original Article
  • Published:
Esophagus Aims and scope Submit manuscript

Abstract

Objective

We compared the clinicopathologic features between mesenchymal tumors located in the esophagogastric junction (EGJ) and upper stomach, that had been removed surgically.

Methods

Thirty-five patients with a submucosal tumor (SMT) of the stomach, including the EGJ, were surgically treated over the last decade. Of these, 23 patients with SMTs located in the upper third of the stomach (n = 15; UG-group) and EGJ (n = 8; EGJ-group) were studied.

Results

The mean age was younger in the EGJ-group than in the UG-group, and the EGJ-group frequently showed symptoms. Histopathologically, 4 gastrointestinal stromal tumors (GISTs) and 4 leiomyomas were observed in the EGJ-group, while 14 GISTs and one schwannoma were observed in the UG-group (p = 0.0096). Two tumors macroscopically showed a horseshoe or spiral type in the EGJ-group, while all tumors showed a ball/ball-like appearance in the UG-group. Regarding surgical procedures, 7 patients underwent laparotomy in the EGJ-group, while 9 patients underwent laparoscopic surgery in the UG-group. The mean operating time was longer and operative bleeding was greater in the EGJ-group than in the UG-group, respectively (p = 0.0015 and p = 0.0095). Postoperative complications were frequently observed in the EGJ-group. The EGJ-group showed no patients with recurrence and/or metastasis after surgery, while three cases with GISTs had them in the UG-group. In GISTs, the mean mitotic index of the UG-group was relatively more than that of the EGJ-group and a case was classified into the high-risk group, although there was no significance in the risk classification between the two groups.

Conclusion

SMTs included GISTs and leiomyomas in the EGJ, while the majority demonstrated GISTs in the upper stomach. SMTs of the EGJ were removed by a tailored approach to prevent recurrence as well as postoperative complications. The biological behavior of GISTs may be different between the EJG and stomach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152:1259–69.

    PubMed  CAS  Google Scholar 

  2. Klüppel M, Huizinga JD, Malysz J, Bernstein A. Developmental origin and Kit-dependent development of the interstitial cells of Cajal in the mammalian small intestine. Dev Dyn. 1998;211:60–71.

    Article  PubMed  Google Scholar 

  3. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol. 1999;23:377–89.

    Article  PubMed  CAS  Google Scholar 

  4. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51–8.

    Article  PubMed  CAS  Google Scholar 

  5. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29:52–68.

    Article  PubMed  Google Scholar 

  6. Miettinen M, Lasota J. Gastrointestinal stromal tumors–definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchow Arch. 2001;438:1–12.

    Article  CAS  Google Scholar 

  7. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol. 2000;24:211–22.

    Article  PubMed  CAS  Google Scholar 

  8. Abraham SC, Krasinskas AM, Hofstetter WL, Swisher SG, Wu TT. “Seedling” mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction. Am J Surg Pathol. 2007;31:1629–35.

    Article  PubMed  Google Scholar 

  9. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23:70–83.

    Article  PubMed  Google Scholar 

  10. Japan Esophageal Society. Japanese classification of esophageal cancer, tenth edition: parts II and III. Esophagus. 2009;6:71–94.

    Article  Google Scholar 

  11. Takubo K, Nakagawa H, Tsuchiya S, Mitomo Y, Sasajima K, Shirota A. Seeding leiomyoma of the esophagus and esophagogastric junction zone. Hum Pathol. 1981;12:1006–10.

    Article  PubMed  CAS  Google Scholar 

  12. Agaimy A, Wünsch PH. Sporadic Cajal cell hyperplasia is common in resection specimens for distal oesophageal carcinoma. A retrospective review of 77 consecutive surgical resection specimens. Virchows Arch. 2006;448:288–94.

    Article  PubMed  Google Scholar 

  13. Chetty R. Small and microscopically detected gastrointestinal stromal tumours: an overview. Pathology. 2008;40:9–12.

    Article  PubMed  Google Scholar 

  14. Antoch G, Kanja J, Bauer S, Kuehl H, Renzing-Koehler K, Schuette J, Bockisch A, Debatin JF, Freudenberg LS. Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. J Nucl Med. 2004;45:357–65.

    PubMed  CAS  Google Scholar 

  15. Gayed I, Vu T, Iyer R, Johnson M, Macapinlac H, Swanston N, Podoloff D. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J Nucl Med. 2004;45:17–21.

    PubMed  CAS  Google Scholar 

  16. Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol. 2007;25:1753–9.

    Article  PubMed  Google Scholar 

  17. Kitajima K, Murakami K, Kaji Y, Sugimura K. Spectrum of FDG PET/CT findings of uterine tumors. AJR Am J Roentgenol. 2010;195:737–43.

    Article  PubMed  Google Scholar 

  18. Novitsky YW, Kercher KW, Sing RF, Heniford BT. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg. 2006;243:738–45.

    Article  PubMed  Google Scholar 

  19. Sexton JA, Pierce RA, Halpin VJ, Eagon JC, Hawkins WG, Linehan DC, Brunt LM, Frisella MM, Matthews BD. Laparoscopic gastric resection for gastrointestinal stromal tumors. Surg Endosc. 2008;22:2583–7.

    Article  PubMed  Google Scholar 

  20. Sasaki A, Koeda K, Obuchi T, Nakajima J, Nishizuka S, Terashima M, Wakabayashi G. Tailored laparoscopic resection for suspected gastric gastrointestinal stromal tumors. Surgery. 2010;147:516–20.

    Article  PubMed  Google Scholar 

  21. Aogi K, Hirai T, Mukaida H, Toge T, Haruma K, Kajiyama G. Laparoscopic resection of submucosal gastric tumors. Surg Today. 1999;29:102–6.

    Article  PubMed  CAS  Google Scholar 

  22. Song KY, Kim SN, Park CH. Tailored-approach of laparoscopic wedge resection for treatment of submucosal tumor near the esophagogastric junction. Sur Endosc. 2007;21:2272–6.

    Article  Google Scholar 

  23. Coccolini F, Catena F, Ansaloni L, Lazzareschi D, Pinna AD. Esophagogastric junction gastrointestinal stromal tumor: resection vs enucleation. World J Gastroenterol. 2010;16:4374–6.

    Article  PubMed  Google Scholar 

  24. Koide N, Kishimoto K, Komatsu O, Yoshizawa A, Sugiyama A, Miyagawa S. Thoracoscopic enucleation of esophageal stromal tumor. Dis Esophagus. 2004;17(1):104–8.

    Article  PubMed  CAS  Google Scholar 

  25. Yamada H, Shinohara T, Yokoyama K, Takasu K, Fujimori Y, Yamagishi K. Thoracoscopic enucleation of esophageal gastrointestinal stromal tumor using prone positioning in a patient with severe chronic obstructive lung disease. J Laparoendosc Adv Surg Tech A. 2011;21:635–9.

    Article  PubMed  Google Scholar 

  26. von Rahden BH, Stein HJ, Feussner H, Siewert JR. Enucleation of submucosal tumors of the esophagus: minimally invasive versus open approach. Surg Endosc. 2004;18:924–30.

    Article  Google Scholar 

  27. Jiang G, Zhao H, Yang F, Li J, Li Y, Liu Y, Liu J, Wang J. Thoracoscopic enucleation of esophageal leiomyoma: a retrospective study on 40 cases. Dis Esophagus. 2009;22:279–83.

    Article  PubMed  CAS  Google Scholar 

  28. Nishida T, Hirota S, Yanagisawa A, Sugino Y, Minami M, Yamamura Y, GIST Guideline Subcommittee, et al. Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version. Int J Clin Oncol. 2008;13:416–30.

    Article  PubMed  Google Scholar 

  29. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459–65.

    Article  PubMed  Google Scholar 

  30. Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol. 2002;33:669–76.

    Article  PubMed  Google Scholar 

  31. Liszka Ł, Zielińska-Pajak E, Pajak J, Gołka D, Huszno J. Coexistence of gastrointestinal stromal tumors with other neoplasms. J Gastroenterol. 2007;42:641–9.

    Article  PubMed  Google Scholar 

  32. Gonçalves R, Linhares E, Albagli R, Valadão M, Vilhena B, Romano S, Ferreira CG. Occurrence of other tumors in patients with GIST. Surg Oncol. 2010;19:e140–3.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Surgery, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan

    Tetsuya Umesaki, Naohiko Koide, Motohiro Okumura, Daisuke Takeuchi, Akira Suzuki & Shinichi Miyagawa

Authors
  1. Tetsuya Umesaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naohiko Koide
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Motohiro Okumura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daisuke Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Akira Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shinichi Miyagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naohiko Koide.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Umesaki, T., Koide, N., Okumura, M. et al. Clinicopathologic differences of mesenchymal submucosal tumors between the esophagogastric junction and the upper stomach. Esophagus 10, 20–26 (2013). https://doi.org/10.1007/s10388-013-0361-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10388-013-0361-0

Keywords

Search

Navigation